|
Consolidated Statements of Loss and Comprehensive Loss (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
| Consolidated Statements of Loss and Comprehensive Loss [Abstract] | ||||
| COLLABORATION REVENUE [note3] | $ 2,429 | $ 1,887 | $ 3,745 | $ 3,086 |
| EXPENSES | ||||
| Research and development | 6,326 | 5,409 | 11,408 | 10,262 |
| General and administrative | 2,047 | 1,471 | 3,784 | 3,042 |
| Total expenses | 8,373 | 6,880 | 15,192 | 13,304 |
| LOSS FROM OPERATIONS | 5,944 | 4,993 | 11,447 | 10,218 |
| OTHER INCOME (EXPENSE) | ||||
| Interest income | 91 | 63 | 141 | 119 |
| Other | (6) | 87 | 17 | 83 |
| (Loss) gain on warrants [notes 4 and 5] | 1,644 | (1,687) | 214 | 441 |
| Total other income (expense) | 1,729 | (1,573) | 372 | 643 |
| Loss for the period before income taxes | 4,215 | 6,530 | 11,075 | 9,575 |
| Income taxes | ||||
| Net loss | 4,215 | 6,530 | 11,075 | 9,575 |
| OTHER COMPREHENSIVE INCOME (LOSS) | ||||
| Net unrealized loss on securities | (19) | (54) | (19) | (3) |
| Total other comprehensive (loss) income | (19) | (54) | (19) | (3) |
| Total comprehensive loss | $ 4,234 | $ 6,584 | $ 11,094 | $ 9,578 |
| Basic and diluted loss per common share [note 5(c)] | $ 0.29 | $ 0.67 | $ 0.89 | $ 0.99 |
| Weighted average number of common shares [note 5(c)] basic and diluted | 14,554,502 | 9,718,251 | 12,394,869 | 9,715,846 |
| X | ||||||||||
|
- Definition
Gain on warrants [note 5]. No definition available.
|
| X | ||||||||||
|
- Definition
Revenues from collaborative agreements. No definition available.
|
| X | ||||||||||
|
- Definition
Unrealized loss on cash equivalents and marketable securities. No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average number of common shares [note 5(c)]. No definition available.
|
| X | ||||||||||
|
- Definition
The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total costs of sales and operating expenses for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Income derived from investments in debt securities and on cash and cash equivalents the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
Net of tax amount of other comprehensive income (loss) attributable to both parent entity and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|